title: The GILDA trial finds no survival benefit from intensified screening after primary resection of colorectal cancer: the PulMiCC trial tests the survival benefit of pulmonary metastasectomy for detected asymptomatic lung metastases.
authors.affiliation: Department of Cardiothoracic Surgery, Clinical Operational Research Unit, UCL, London tom.treasure@gmail.com.
authors.forename: T
authors.initials: T
authors.lastname: Treasure
authors.affiliation: Wales Cancer Trial Unit, Cardiff University, Cardiff, UK.
authors.forename: F
authors.initials: F
authors.lastname: Macbeth
mesh_terms: D015179:Colorectal Neoplasms; D006801:Humans; D008175:Lung Neoplasms; D059146:Metastasectomy; D011013:Pneumonectomy; D012189:Retrospective Studies; D015996:Survival Rate